Skip to main content
TipRanks
Go Ultimate75% OFF

Enovis (0I1B) Share Price & Analysis

2 Followers

0I1B Stock Chart & Stats

$27.46-$0.53(-1.89%)
At close: 4:30 PM GMT
$20$25Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$27.46 - $28.44
52-Week Range
$16.73 - $32.21
Previous Close
$27.99
Volume
N/A
Average Volume (3M)
999
Market Cap
$1.57B
Enterprise Value
$2.37B
Total Cash (Recent Filing)
$65.35M
Total Debt (Recent Filing)
$1.34B
Price to Earnings (P/E)
―
Beta
1.06
Next Earnings
Feb 25, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Accelerating Revenue Growth

The sharp acceleration in revenue indicates stronger commercial traction across Enovis’s orthopedic and recovery portfolio. If sustained, expanding sales provide greater operating leverage, support investment in innovation, and strengthen the company’s ability to build scale across hospitals, surgeons, and outpatient channels.

Improving Cash Generation

Improving operating cash flow and a return to positive free cash flow provide tangible support for the business despite accounting losses. Better cash conversion can fund product development, integration work, and debt reduction, while increasing financial flexibility over the next several quarters.

Expanding Surgical Technology Platform

The proposed robotics acquisition could broaden Enovis’s offering from implants and instruments into planning, navigation, assistance, and robotic surgery. That wider ecosystem may deepen relationships with hospitals and ambulatory centers while creating a platform for future procedure-driven growth.

Bears Say

Persistent Net Losses

Deep net losses remain the clearest fundamental weakness and show that revenue growth has not yet translated into GAAP profitability. Continued losses can constrain retained capital, weaken returns on equity, and make the business more dependent on successful operating improvement and cash discipline.

Higher Financial Leverage

Rising leverage reduces financial flexibility while Enovis is still absorbing losses and funding strategic expansion. Additional debt tied to the robotics transaction could increase interest and repayment demands, leaving less capacity to withstand weaker procedures or invest through a slower operating period.

Margin And Demand Pressure

Underlying gross-margin pressure suggests that pricing competition, unfavorable mix, and higher input and distribution costs can offset productivity gains. If these forces persist, they could limit the conversion of strong revenue growth into durable earnings and cash-flow improvement.

Enovis News

0I1B FAQ

What was Enovis’s price range in the past 12 months?
Enovis lowest share price was $16.73 and its highest was $32.21 in the past 12 months.
What is Enovis’s market cap?
Enovis’s market cap is $1.57B.
When is Enovis’s upcoming earnings report date?
Enovis’s next earnings report is estimated for Feb 25, 2027 (not yet confirmed), which is in 99 days.
How were Enovis’s earnings last quarter?
Enovis released its earnings results on Nov 05, 2026. The company reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.767 by $0.113.
Is Enovis overvalued?
According to Wall Street analysts Enovis’s price is currently Undervalued.
Does Enovis pay dividends?
Enovis does not currently pay dividends.
What is Enovis’s EPS estimate?
Enovis’s EPS estimate is 1.03.
How many shares outstanding does Enovis have?
Enovis has 57,694,805 shares outstanding.
What happened to Enovis’s price movement after its last earnings report?
Enovis reported an EPS of $0.88 in its last earnings report, beating expectations of $0.767. Following the earnings report the stock price went up 13.909%.
Which hedge fund is a major shareholder of Enovis?
Hedge funds hold Enovis shares: the largest hedge-fund position in Enovis is 513,977,869 shares, and hedge funds decreased their holdings by 563.8K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology